Clinical Trial Update: Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing insulin detemir with insulin semilente in type 1 diabetes has completed. The sponsor is Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Semilente (insulin semilente)
• Insulin detemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED